Recent publications in medical microbiology and immunology: a retrospective

[1]  E. Mignot,et al.  Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china , 2011, Annals of neurology.

[2]  J. Miklossy,et al.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria , 2011, Journal of Neuroinflammation.

[3]  D. Krüger,et al.  Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava–Belgrade hantaviruses , 2011, Medical Microbiology and Immunology.

[4]  H. Doerr,et al.  Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression , 2011, PloS one.

[5]  P. Wutzler,et al.  Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate , 2011, Medical Microbiology and Immunology.

[6]  D. Krüger,et al.  Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection , 2011, Medical Microbiology and Immunology.

[7]  J. Schneider-Mergener,et al.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity , 2011, Medical Microbiology and Immunology.

[8]  R. Zell,et al.  Current knowledge on PB1-F2 of influenza A viruses , 2011, Medical Microbiology and Immunology.

[9]  R. Zell,et al.  Monitoring prevalence of varicella-zoster virus clades in Germany , 2011, Medical Microbiology and Immunology.

[10]  Meili Li,et al.  Screening and identification of host factors interacting with UL14 of herpes simplex virus 1 , 2011, Medical Microbiology and Immunology.

[11]  H. Doerr,et al.  Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010 , 2011, Infection.

[12]  J. Cinatl,et al.  Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet , 2011, Medical Microbiology and Immmunology.

[13]  Ying Zhang,et al.  A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice , 2011, Medical Microbiology and Immunology.

[14]  R. Allwinn.  Significant increase in travel-associated dengue fever in Germany , 2011, Medical Microbiology and Immunology.

[15]  Jindrich Cinatl,et al.  Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses , 2011, Medical Microbiology and Immunology.

[16]  H. Doerr,et al.  Oncomodulation by human cytomegalovirus: novel clinical findings open new roads , 2011, Medical Microbiology and Immunology.

[17]  Thomas Lengauer,et al.  Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients , 2011, Medical Microbiology and Immunology.

[18]  L. Mannonen,et al.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts , 2011, Medical Microbiology and Immunology.

[19]  H. Doerr,et al.  Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses , 2010, Phytomedicine.

[20]  S. Staszewski,et al.  Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis , 2010, Medical Microbiology and Immunology.

[21]  R. Raggam,et al.  Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR , 2010, Medical Microbiology and Immunology.

[22]  K. Boller,et al.  Pro-autophagic signal induction by bacterial pore-forming toxins , 2010, Medical Microbiology and Immunology.

[23]  J. Hacker,et al.  Genome dynamics and its impact on evolution of Escherichia coli , 2010, Medical Microbiology and Immunology.

[24]  Gregor Kuhlenbäumer,et al.  Chlamydia pneumoniae infection and Alzheimer’s disease: a connection to remember? , 2010, Medical Microbiology and Immunology.

[25]  M. Zimecki,et al.  Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus , 2010, Medical Microbiology and Immunology.

[26]  H. Doerr,et al.  Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells , 2010, Medical Microbiology and Immunology.

[27]  J. Lipuma,et al.  Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine , 2010, Medical Microbiology and Immunology.

[28]  F. Brombacher,et al.  CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation , 2010, Medical Microbiology and Immunology.

[29]  J. Morschhäuser.  Regulation of white-opaque switching in Candida albicans , 2010, Medical Microbiology and Immunology.

[30]  J. Schneider-Schaulies,et al.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy , 2010, Medical Microbiology and Immunology.

[31]  K. Schmitt,et al.  Resemblance and divergence: the “new” members of the genus Bordetella , 2010, Medical Microbiology and Immunology.

[32]  H. Doerr,et al.  Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages , 2010, Medical Microbiology and Immunology.

[33]  O. Kurzai,et al.  Virulence determinants involved in differential host niche adaptation of Neisseriameningitidis and Neisseria gonorrhoeae , 2010, Medical Microbiology and Immunology.

[34]  U. Vogel,et al.  Biofilm formation by the human pathogen Neisseria meningitidis , 2010, Medical Microbiology and Immunology.

[35]  Evelyn Gassert,et al.  Measles virus-induced immunosuppression: from effectors to mechanisms , 2010, Medical Microbiology and Immunology.

[36]  K. Brehm.  The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host–parasite interaction , 2010, Medical Microbiology and Immunology.

[37]  H. Doerr,et al.  Regional spread of HIV-1 M subtype B in middle-aged patients by random env-C2V4 region sequencing , 2010, Medical Microbiology and Immunology.

[38]  A. Berger,et al.  Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? , 2010, Medical Microbiology and Immunology.

[39]  M. Rumbo,et al.  Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization , 2010, Medical Microbiology and Immunology.

[40]  H. Doerr,et al.  Epidemiology of Human Cytomegalovirus (HCMV) in an urban region of Germany: what has changed? , 2010, Medical Microbiology and Immunology.

[41]  S. Zeuzem,et al.  Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation , 2010, Medical Microbiology and Immunology.

[42]  Madhan Kumar,et al.  Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India , 2010, Medical Microbiology and Immunology.

[43]  H. Doerr,et al.  Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany , 2010, Medical Microbiology and Immunology.

[44]  H. Doerr,et al.  Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed? , 2009, Medical Microbiology and Immunology.

[45]  H. Doerr,et al.  Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method , 2009, Medical Microbiology and Immunology.

[46]  Arif A. Khan,et al.  Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles , 2009, Medical Microbiology and Immunology.

[47]  R. Roop,et al.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host , 2009, Medical Microbiology and Immunology.

[48]  H. Doerr,et al.  An influenza A H1N1 virus revival – pandemic H1N1/09 virus , 2009, Infection.

[49]  R. Allwinn,et al.  Against the new H1N1 influenza (swine influenza): Vaccinate or don’t vaccinate (all)? That is currently the question! , 2009, Infection.

[50]  J. Schmidt-Chanasit,et al.  Ross River virus infection in a traveller returning from northern Australia , 2009, Medical Microbiology and Immunology.

[51]  J. Cinatl,et al.  The clinical value of neutrophil extracellular traps , 2009, Medical Microbiology and Immunology.

[52]  Jindrich Cinatl,et al.  Novel swine-origin influenza A virus in humans: another pandemic knocking at the door , 2009, Medical Microbiology and Immunology.

[53]  M. Seman,et al.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity , 2009, Medical Microbiology and Immunology.

[54]  H. Doerr,et al.  Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus , 2009, Medical Microbiology and Immunology.

[55]  M. Maurer,et al.  What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis , 2009, Medical Microbiology and Immunology.

[56]  Y. Qi,et al.  Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants , 2009, Medical Microbiology and Immunology.

[57]  H. Doerr,et al.  Of chickens and men: avian influenza in humans. , 2009, Current molecular medicine.

[58]  C. Drosten,et al.  No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka , 2009, Medical Microbiology and Immunology.

[59]  H. Doerr,et al.  Oncomodulation by human cytomegalovirus: evidence becomes stronger , 2009, Medical Microbiology and Immunology.

[60]  Mahavir Singh,et al.  Buruli ulcer disease: prospects for a vaccine , 2009, Medical Microbiology and Immunology.

[61]  R. Schmidt-Ott,et al.  Seroprevalence of influenza A and B in German infants and adolescents , 2009, Medical Microbiology and Immunology.

[62]  V. Sreenivas,et al.  Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals , 2009, Medical Microbiology and Immunology.

[63]  A. Folgori,et al.  Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients , 2009, Medical Microbiology and Immunology.

[64]  S. Mitarai,et al.  Comparison of performance in two diagnostic methods for tuberculosis infection , 2009, Medical Microbiology and Immunology.

[65]  Wei Liu,et al.  Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice , 2009, Medical Microbiology and Immunology.

[66]  M. Groschup,et al.  Seroepidemiological study in a Puumala virus outbreak area in South-East Germany , 2009, Medical Microbiology and Immunology.

[67]  J. Miklossy.  Alzheimer's disease – a neurospirochetosis , 2008 .

[68]  H. Doerr,et al.  Novel Varicella-Zoster Virus Glycoprotein E Gene Mutations Associated with Genotypes A and D , 2007, Journal of Clinical Microbiology.

[69]  H. Doerr,et al.  The threat of avian influenza A (H5N1). Part IV: development of vaccines , 2007, Medical Microbiology and Immunology.

[70]  H. Doerr,et al.  The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants , 2007, Medical Microbiology and Immunology.

[71]  A. Kamarulzaman.  Med Microbiol Immunol , 2006 .

[72]  R. Allwinn,et al.  Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter , 2006, Medical Microbiology and Immunology.

[73]  K. Lackner,et al.  Beyond cholesterol: the enigma of atherosclerosis revisited , 2004, Thrombosis and Haemostasis.

[74]  H. Doerr,et al.  Laboratory diagnosis of influenza – virology or serology? , 2002, Medical Microbiology and Immunology.

[75]  D. Appelt,et al.  Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.

[76]  M. Bickel,et al.  Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.